| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3627929
Max Phase: Preclinical
Molecular Formula: C20H17ClN2
Molecular Weight: 284.36
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: Cl.NCc1cc(-c2ccccc2)nc2c1ccc1ccccc12
Standard InChI: InChI=1S/C20H16N2.ClH/c21-13-16-12-19(15-7-2-1-3-8-15)22-20-17-9-5-4-6-14(17)10-11-18(16)20;/h1-12H,13,21H2;1H
Standard InChI Key: RZQLIGJQRCSJBS-UHFFFAOYSA-N
Associated Targets(Human)
Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 1 17 Activities
Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 180 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 284.36 | Molecular Weight (Monoisotopic): 284.1313 | AlogP: 4.51 | #Rotatable Bonds: 2 |
| Polar Surface Area: 38.91 | Molecular Species: BASE | HBA: 2 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 9.29 | CX LogP: 4.28 | CX LogD: 2.42 |
| Aromatic Rings: 4 | Heavy Atoms: 22 | QED Weighted: 0.55 | Np Likeness Score: -0.53 |
References
| 1. Russo CM, Adhikari AA, Wallach DR, Fernandes S, Balch AN, Kerr WG, Chisholm JD.. (2015) Synthesis and initial evaluation of quinoline-based inhibitors of the SH2-containing inositol 5'-phosphatase (SHIP)., 25 (22): [PMID:26453006] [10.1016/j.bmcl.2015.09.034] |
Source
Source(1):